Abstract
The I-SPY 2 breast cancer clinical trial paves the way for multi-arm adaptive learning trials. The I-SPY 2 breast cancer clinical trial paves the way for multi-arm adaptive learning trials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have